2,2,13,13-tetramethyl-3,6,9,12-tetraoxatetradecane

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2,2,13,13-tetramethyl-3,6,9,12-tetraoxatetradecane
• 英文别名: 2-Methyl-2-[2-[2-[2-[(2-methylpropan-2-yl)oxy]ethoxy]ethoxy]ethoxy]propane
• 化学式: C₁₄H₃₀O₄
• 分子量: 262.39
• InChiKey: GAJGAZRKKYSWTG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  18
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  36.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  potassium tert-butylate 、 三乙二醇二(对甲苯磺酸酯) 以 叔丁醇 为溶剂， 反应 4.0h， 以32%的产率得到2,2,13,13-tetramethyl-3,6,9,12-tetraoxatetradecane
  参考文献：
  名称：

  从 N,N-二[低聚(氧化烯)]胺和低聚乙二醇二(对甲苯磺酸盐)或相应的二氯化物合成单氮杂冠醚

  摘要：

  通过二乙醇胺或 N,N-二[低聚(氧乙烯)]胺与低聚乙二醇二(对甲苯磺酸盐)或相应的二氯化物在叔丁醇/二恶烷中的一步反应制备了单氮杂冠醚，收率令人满意。存在叔丁醇钠或钾。研究了制备单氮杂15-和18-冠醚的反应条件。还制备了各种具有取代基的单氮杂冠醚并研究了它们的性质。

  DOI：

  10.1246/bcsj.56.212

文献信息

• TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE
  申请人：Arvinas, Inc.

  公开号：US20180125821A1

  公开（公告）日：2018-05-10

  The present disclosure relates to bifunctional compounds, which find utility as modulators of tau protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tau protein, such that tau protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tau. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tau protein. Diseases or disorders that result from aggregation or accumulation of tau protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为tau蛋白的调节剂具有实用性。具体而言，本公开涉及含有一端结合到E3泛素连接酶的VHL或cereblon配体，另一端结合到tau蛋白的双功能化合物，使得tau蛋白与泛素连接酶靠近，以实现tau蛋白的降解（和抑制）。本公开展示了与tau蛋白降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由tau蛋白聚集或积累导致的疾病或紊乱。
• CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
  申请人：Arvinas, Inc.

  公开号：US20180215731A1

  公开（公告）日：2018-08-02

  The description relates to cereblon E3 ligase binding compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present disclosure. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

  该描述涉及cereblon E3连接酶结合化合物，包括包含相同成分的双功能化合物，这些化合物作为靶向泛素化的调节剂具有实用价值，尤其是抑制剂，可降解和/或以其他方式抑制根据本公开的双功能化合物。特别是，该描述提供了化合物，其一端含有与cereblon E3泛素连接酶结合的配体，另一端含有与目标蛋白结合的部分，使目标蛋白位于泛素连接酶附近以降解（和抑制）该蛋白。可以合成表现出广泛药理活性的化合物，与几乎所有类型的靶向多肽的降解/抑制一致。
• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ENHANCER OF ZESTE HOMOLOG 2 POLYPEPTIDE
  申请人：Arvinas, Inc.

  公开号：US20180177750A1

  公开（公告）日：2018-06-28

  The present disclosure relates to bifunctional compounds, which find utility as modulators of enhancer of zeste homolog 2 (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为增强子锁定同源2的调节剂而发挥作用。具体而言，本公开涉及包含一端为Von Hippel-Lindau、cereblon、凋亡抑制蛋白或鼠双分子同源2配体的双功能化合物，该配体与相应的E3泛素连接酶结合，另一端含有结合目标蛋白的基团，使目标蛋白靠近泛素连接酶以实现目标蛋白的降解（和抑制）。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
• Facile synthesis of monoaza crown ethers
  作者：Hirokazu Maeda、Yohji Nakatsuji、Mitsuo Okahara

  DOI：10.1039/c39810000471

  日期：——

  A facile one-step synthesis of monoaza crown ethers by treatment of dialkanolamines with oligothylene glycol di(toluene-p-sulphonates) or dichlorides in ButOM–ButOH (M = Na, K) is described.

  通过用oligothylene乙二醇二（甲苯二烷醇胺的一氮杂冠醚的一种简便一步法合成p -sulphonates）或二氯化物在卜吨OM-卜吨OH（M =钠，钾）进行说明。
• SEALING AGENT FOR PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME
  申请人：NIPPON KAYAKU KABUSHIKI KAISHA

  公开号：EP1598897A1

  公开（公告）日：2005-11-23

  A sealing agent for a photoelectric conversion device which comprises one or more of a compound having a glycidyl structure, a compound having a cyclohexene oxide structure, a compound having an oxetane structure and a compound having a vinyl ether structure, and a cationic polymerization initiator; a photoelectric conversion device using the sealing agent; and a solar cell comprising the photoelectric conversion device. The sealing agent for a photoelectric conversion device can be used for pasting together upper and lower electroconductive glass substrates at an ordinary temperature in the manufacture of a photoelectric conversion device, and is excellent with respect to adhesion strength and the reliability in moisture resistance.

  一种用于光电转换装置的密封剂，它包括具有缩水甘油结构的化合物、具有环己烯氧化结构的化合物、具有氧杂环丁烷结构的化合物和具有乙烯基醚结构的化合物中的一种或多种，以及阳离子聚合引发剂；一种使用该密封剂的光电转换装置；以及一种包含该光电转换装置的太阳能电池。用于光电转换装置的密封剂可用于在制造光电转换装置时在常温下将上下导电玻璃基板粘贴在一起，并具有出色的粘合强度和防潮可靠性。